Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery. The appointment reflects the company’s commitment to deepen client collaboration, enhance the ...
read more
Oncodesign Services, a Contract Research Organization (CRO) specialized in drug discovery and preclinical services in oncology and immuno-inflammation, announced the execution of a Preclinical License and Supply Agreement
read more
Oncodesign Services and Veritas In Silico Inc have entered into a Memorandum of Understanding (“MOU”) to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA (“mRNA”).
read more
Thursday, January 25, 2024
Oncodesign Services (ODS), a Contract Research Organization specialized in drug discovery and preclinical services, announces its acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery.
read more
Oncodesign has formed a new strategic alliance with HitGen, a Chinese biotech company.
read more
Wednesday, November 07, 2018
Oncodesign announced a service partnership with Galderma, a dermatological unit belonging to Nestlé Skin Health.
read more
Oncobiologics has entered into a MSA with Sonnet BioTherapeutics, a privately held development stage biopharmaceutical company, and has officially launched its BioSymphony Platform.
read more
Onco360® announced it has been selected as a specialty pharmacy network partner for Karyopharm’s new product XPOVIO™ (selinexor).
read more
Friday, November 30, 2018
Onco360 announced it was selected as a specialty pharmacy network partner for Astellas’ new product Xospata (gilteritinib).
read more
Onco360 has been selected to participate in the limited distribution network of Braftovi and Mektovi for the treatment of patients with unresectable or metastatic melanoma.
read more
OnAsset Intelligence Inc.(OnAsset), the market leader in machine-to-machine (M2M) airborne asset tracking solutions, announced today that US Airways has joined the ranks of major airline operators now accepting the company’s SENTRY FlightSafe® ...
read more
Alongside its dynamic growth, Vetter announced that it achieved its sustainability goals for 2023. The Contract Development & Manufacturing Organization (CDMO) recently became a member of SBTi and is therefore committed to meeting strict CO2 ...
read more
Officially opened on 15th March 2016, Omya’s new pharmaceutical and nutraceutical laboratory is now operational. The innovative facility at the company’s Swiss headquarters in Oftringen comprises a wet lab for product development, a dry lab for ...
read more
Omya has rebuilt and expanded its calcium carbonate production plant in Orgon, France, creating a substantially higher capacity for its functionalized calcium carbonate product platform, a new packaging line and an on-site warehouse.
read more
omniQ has expanded its AI-based solutions into the 1.2-billion-person, African market.
read more